Global Drug of Abuse Testing Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Product, by Sample, and by End-User

The global drug of abuse testing market accounted for $4,407.8 million in 2015 and it is expected to grow at a CAGR of 9.6% during 2016-2022. Between the two products, the consumable segment held the larger share(56%) in the global market in 2015. Among the various sample types, the urine testing segment held the largest share; while, the hospital segment held the largest share among the various end-users in the global market in 2015. The global drug of abuse testing market is witnessing high growth,due to increased availability of drugs, increased consumption, increased drug of abuse testing at organizational levels, and efforts to decrease the road accidents caused by of the consumption of drugs.

The increased production and trafficking of illegal drugs is one of the major factors leading to increased demand for drug of abuse testing. This is also responsible for increased drug-related death and accidents and loss of productivity at work. According to United Nations (UN) publication, approximately 200,000 people die every year, due to drug of abuse related death. The increased utilization of drug of abuse testing may prevent such incidents by increased monitoring of people consuming illicit drug.

In addition, increasing alcohol consumption and increased number of road accident due to drunk driving are leading to increased road accidents. According to Centers for Disease Control and Prevention publication, alcohol related accidents accounts for approximately one-third of all traffic related deaths, while driving under the influence of alcohol or drugs has led to approximately 1.1 million arrests in 2014 in the U.S. The potential mishaps due to alcohol consumption can be checked, and improved road traffic safety can be achieved by increased utilization of breath analyzer. Moreover, according to National Institute of Alcohol Abuse and Alcoholism publication, approximately 87.6% people aged 18 years or older consumed alcohol at some point in lifetime in the U.S. The increased utilization of breath analyzers are expected to increase identification, monitoring and prevention of potential mishaps caused by alcohol consumption.

An emphasis is being laid on workplace safety, in order to increase safety and productivity of the employees across the globe. In addition, the global increase in road accidents and death rates,due to drugs consumption is expected to increase the demand of drug of abuse testing, which will help in reducing the potential number of incidences and loss of life.The technological advancements are also being used for the development of drug of abuse testing products, and improving their analytical capabilities.

The restraints associated with the growth of the global drug of abuse testing market include the legalization of drugs, social issues associated with drug of abuse testing, and inability to detect low–dose designer drugs. Legalization of drugs has taken place in some countries, due to which, it will affect the associated products for drug of abuse testing. The presence of positive results during drug of abuse testing is considered as social stigma, and it may lead to professional repercussions. The inability of testing devices to detect low–dose designer drugs leads to potential chances of mishap and allow people to continue their consumption.

Some of the key companies operating in the global drug of abuse testing market include Siemens HealthcareAG,, F. Hoffmann-La Roche Ltd., Millipore Sigma, Danaher Corporation, Alere Inc., Abbott Laboratories, Drägerwerk AG & Co. KGAA, Express Diagnostics Int'l, Inc. Shimadzu Corporation, Waters Corporation, bioMérieux SA, Quest Diagnostics Inc., Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Psychemedics Corporation, Sonic Healthcare Ltd. Thermo Fisher Scientific Inc., and Bio-Rad Laboratories.

Download the full report: https://www.reportbuyer.com/product/4087597/